James A. Rogers, Ph.D.

VIce President of Statistics, Quantitative Sciences

Jim Rogers has over 20 years of experience as an applied statistician in the biomedical industry. He currently provides statistical leadership for Quantitative Sciences at Metrum Research Group. Prior to joining Metrum Research Group, Jim worked for five years at Pfizer Global Research and Development, where he was the statistical lead on numerous clinical and preclinical projects in neuroscience. In 2008, Jim joined Metrum Research Group in order to work in closer collaboration with quantitative biologists and pharmacometricians. From a methodological perspective, Jim’s focus in recent years has centered on the role of causal inference concepts in evidence integration. Jim believes that scientists trained in statistics can revolutionize the discipline of pharmacometrics and that scientists trained in pharmacometrics can revolutionize the discipline of statistics.

Recent publications by this scientist

Landmark and longitudinal exposure-response analyses for multiple efficacy and safety endpoints to justify the clinical dose of valemetostat for adult T-cell leukemia/lymphoma

December 15, 2022

Masato Fukae, Kyle Baron, James Rogers, Ramon Garcia, Masaya Tachibana, John Mondick, Takako Shimizu. Poster presented at 2022 American Conference on Pharmacometrics (ACoP13). 30 October – November 2 2022. Poster M-026

Download PDF

An Introduction to Causal Inference for Pharmacometricians

November 17, 2022

James Rogers, Hugo Maas, Alejandro Perez PitarchCPT Pharmacometrics Syst Pharmacol.  November, 16 2022. doi:10.1002/psp4.12894

View More

Analysis Planning and Interpretation Using Causal Directed Acyclic Graphs: A Case Study in Oncology

October 28, 2022

James A. Rogers, Hugo Maas, Alejandro Peréz. Poster presented at 2022 American Conference on Pharmacometrics (ACoP13). 30 October – November 2 2022. Poster T-022

Download PDF